Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment

• Published in: Antioxidants Vol. 11; no. 10; p. 1854
• Main Authors: Aranda-Rivera, Ana Karina, Cruz-Gregorio, Alfredo, Aparicio-Trejo, Omar Emiliano, Tapia, Edilia, Sánchez-Lozada, Laura Gabriela, García-Arroyo, Fernando Enrique, Amador-Martínez, Isabel, Orozco-Ibarra, Marisol, Fernández-Valverde, Francisca, Pedraza-Chaverri, José
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 20.09.2022; MDPI
• Subjects: Autophagy; B-cell lymphoma; Biosynthesis; CD36 antigen; chronic kidney disease (CKD); Citrate synthase; Diacylglycerol O-acyltransferase; Diglycerides; Dynamin; Fatty-acid synthase; Fibrosis; Hemodynamics; Histology; Homeostasis; Inflammation; Isothiocyanate; Kidney diseases; kidney fibrosis; Kidneys; Laboratory animals; Lipid metabolism; Lipids; Lymphocytes B; Membranes; Metabolism; Microtubule-associated proteins; Mitochondria; mitochondrial biogenesis; mitochondrial dysfunction; Nephropathy; Observations; Oxidative metabolism; Oxidative stress; Proteins; Rodents; Sulforaphane; sulforaphane (SFN); Surgery; Mexico; St Louis Missouri; United States > US; Germany
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox11101854

Unilateral ureteral obstruction (UUO) is an animal rodent model that allows the study of obstructive nephropathy in an accelerated manner. During UUO, tubular damage is induced, and alterations such as oxidative stress, inflammation, lipid metabolism, and mitochondrial impairment favor fibrosis development, leading to chronic kidney disease progression. Sulforaphane (SFN), an isothiocyanate derived from green cruciferous vegetables, might improve mitochondrial functions and lipid metabolism; however, its role in UUO has been poorly explored. Therefore, we aimed to determine the protective effect of SFN related to mitochondria and lipid metabolism in UUO. Our results showed that in UUO SFN decreased renal damage, attributed to increased mitochondrial biogenesis. We showed that SFN augmented peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) and nuclear respiratory factor 1 (NRF1). The increase in biogenesis augmented the mitochondrial mass marker voltage-dependent anion channel (VDAC) and improved mitochondrial structure, as well as complex III (CIII), aconitase 2 (ACO2) and citrate synthase activities in UUO. In addition, lipid metabolism was improved, observed by the downregulation of cluster of differentiation 36 (CD36), sterol regulatory-element binding protein 1 (SREBP1), fatty acid synthase (FASN), and diacylglycerol O-acyltransferase 1 (DGAT1), which reduces triglyceride (TG) accumulation. Finally, restoring the mitochondrial structure reduced excessive fission by decreasing the fission protein dynamin-related protein-1 (DRP1). Autophagy flux was further restored by reducing beclin and sequestosome (p62) and increasing B-cell lymphoma 2 (Bcl2) and the ratio of microtubule-associated proteins 1A/1B light chain 3 II and I (LC3II/LC3I). These results reveal that SFN confers protection against UUO-induced kidney injury by targeting mitochondrial biogenesis, which also improves lipid metabolism.